Greg Galler
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Genetics top 2%
- Inflammatory Bowel Disease
Papers in
-
- Hepatitis C virus research 7
-
- Gastrointestinal motility and disorders 3
- Co-authors
- D. H. Present (1 shared paper)Joel J. Bauer (1 shared paper)Irwin M. Gelernt (1 shared paper)Stephen B. Hanauer (1 shared paper)Fabrizio Michelassi (1 shared paper)Simon Lichtiger (1 shared paper)Asher Kornbluth (1 shared paper)Jonathan McCone (7 shared papers)
- Journals
- Journal of Hepatology (2 papers)New England Journal of Medicine (2 papers)Hepatology (2 papers)Clinical Infectious Diseases (1 paper)Gastroenterology (1 paper)
- Partner nations
- United StatesPhilippinesBelgium
In The Last Decade
Greg Galler
13 papers receiving 2.4k citations
Greg Galler's Hit Papers
Peers
Comparison fields: 5 of 85
- Hepatology 1.0k
- Genetics 1.0k
- Epidemiology 1.1k
- Gastroenterology 115
- Rheumatology 111
Countries citing papers authored by Greg Galler
This map shows the geographic impact of Greg Galler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Galler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Galler more than expected).
Fields of papers citing papers by Greg Galler
This network shows the impact of papers produced by Greg Galler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Galler. The network helps show where Greg Galler may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Galler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy Hit paper breakdown → | 1994 | 1329 |
| 2 | Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection Hit paper breakdown → | 2009 | 915 |
| 3 | 2007 | 57 | |
| 4 | 2014 | 44 | |
| 5 | 2011 | 38 | |
| 6 | 2008 | 32 | |
| 7 | 2010 | 25 | |
| 8 | 2010 | 21 | |
| 9 | 1996 | 19 | |
| 10 | 2014 | 8 | |
| 11 | Impaired Fasting Glucose Is Associated With Lower Rates of Sustained Virologic Response (SVR) in Patients With Genotype 1 Chronic Hepatitis C (CHC): Retrospective Analysis of the IDEAL Study | 2010 | 2 |
| 12 | Hematologic Safety Data From the IDEAL Trial: Neutropenia, Anemia, and Thrombocytopenia Profiles of Peginterferon alfa/Ribavirin | 2008 | 1 |
| 13 | 2012 | 1 |
About Greg Galler
Greg Galler is a scholar working on Hepatology, Gastroenterology, Genetics, Epidemiology and Infectious Diseases, having authored 13 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (7 papers), Gastrointestinal motility and disorders (3 papers), Diabetes and associated disorders (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper), Therapeutic Uses of Natural Elements (1 paper), Blood groups and transfusion (1 paper), Liver Disease Diagnosis and Treatment (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Hepatology (1.0k citations), Genetics (1.0k citations), Epidemiology (1.1k citations), Gastroenterology (115 citations) and Rheumatology (111 citations). Greg Galler has collaborated with scholars based in United States, Philippines and Belgium. Frequent co-authors include D. H. Present, Joel J. Bauer, Irwin M. Gelernt, Stephen B. Hanauer, Fabrizio Michelassi, Simon Lichtiger, Asher Kornbluth, Jonathan McCone, Clifford A. Brass and Stephanie Noviello. Their work appears in journals such as Journal of Hepatology, New England Journal of Medicine, Hepatology, Clinical Infectious Diseases and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.